- Report
- January 2019
- 144 Pages
Global
From €1335EUR$1,375USD£1,152GBP
€2671EUR$2,750USD£2,304GBP
Diovan HCT is a medication used to treat high blood pressure and congestive heart failure. It is a combination of two drugs, valsartan and hydrochlorothiazide, which work together to reduce the amount of fluid in the body and relax the blood vessels, allowing for better blood flow. Diovan HCT is part of the larger cardiovascular drug market, which includes medications used to treat a variety of heart-related conditions, such as high cholesterol, arrhythmia, and coronary artery disease.
The cardiovascular drug market is highly competitive, with many different companies offering a variety of products. Some of the major players in the Diovan HCT market include Novartis, Mylan, and Teva Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Lupin Pharmaceuticals, and Apotex, also offer generic versions of the drug. Show Less Read more